Bibliography

Filters: First Letter Of Keyword is F  [Clear All Filters]
A B C D E [F] G H I J K L M N O P Q R S T U V W X Y Z   [Show ALL]
Facility Regulation and Control
Bos M. Health technology assessment in The Netherlands. Int J Technol Assess Health Care. 2000;16(2):485-519. Abstract
Family Practice
Ebell MH, Siwek J, Weiss BD, Woolf SH, Susman J, Ewigman B, et al. Strength of recommendation taxonomy (SORT): a patient-centered approach to grading evidence in the medical literature. Am Fam Physician. 2004;69(3):548-56. Abstract
Fatigue
Reeve BB, Mitchell SA, Dueck AC, Basch E, Cella D, Reilly CM, et al. Recommended patient-reported core set of symptoms to measure in adult cancer treatment trials. J Natl Cancer Inst. 2014;106(7). Abstract
Feasibility Studies
Sampson M, Shojania KG, McGowan J, Daniel R, Rader T, Iansavichene AE, et al. Surveillance search techniques identified the need to update systematic reviews. J Clin Epidemiol. 2008;61(8):755-62. Abstract
Judson TJ, Bennett AV, Rogak LJ, Sit L, Barz A, Kris MG, et al. Feasibility of long-term patient self-reporting of toxicities from home via the Internet during routine chemotherapy. J Clin Oncol. 2013;31(20):2580-5. Abstract
Federal Government
McDaid D. Co-ordinating health technology assessment in Canada: a European perspective. Health Policy. 2003;63(2):205-13. Abstract
Perry S, Thamer M. Medical innovation and the critical role of health technology assessment. JAMA. 1999;282(19):1869-72.
Female
Judson TJ, Bennett AV, Rogak LJ, Sit L, Barz A, Kris MG, et al. Feasibility of long-term patient self-reporting of toxicities from home via the Internet during routine chemotherapy. J Clin Oncol. 2013;31(20):2580-5. Abstract
Banta HD. Health policy, health technology assessment, and screening in Europe. Int J Technol Assess Health Care. 2001;17(3):409-17. Abstract
Böckerman P, Johansson E, Saarni SI. Do established health-related quality-of-life measures adequately capture the impact of chronic conditions on subjective well-being? Health Policy. 2011;100(1):91-5. Abstract
Lehoux P. Patients' perspectives on high-tech home care: a qualitative inquiry into the user-friendliness of four technologies. BMC Health Serv Res. 2004;4(1):28. Abstract
Lehoux P, Poland B, Daudelin G. Focus group research and "the patient's view". Soc Sci Med. 2006;63(8):2091-104. Abstract
Wild C. [Development and institutionalization of Health Technology Assessment in Austria: the Ludwig Boltzmann Institute for Health Technology Assessment]. Z Evid Fortbild Qual Gesundhwes. 2009;103(6):341-4.
Braunack-Mayer AJ. Ethics and health technology assessment: handmaiden and/or critic? Int J Technol Assess Health Care. 2006;22(3):307-12. Abstract
Faisst K, Schilling J, Koch P. Health technology assessment of three screening methods in Switzerland. Int J Technol Assess Health Care. 2001;17(3):389-99. Abstract
Bombard Y, Abelson J, Simeonov D, Gauvin F-. Eliciting ethical and social values in health technology assessment: A participatory approach. Soc Sci Med. 2011;73(1):135-44. Abstract
Droste S, Herrmann-Frank A, Scheibler F, Krones T. Ethical issues in autologous stem cell transplantation (ASCT) in advanced breast cancer: a systematic literature review. BMC Med Ethics. 2011;12:6. Abstract
Reeve BB, Mitchell SA, Dueck AC, Basch E, Cella D, Reilly CM, et al. Recommended patient-reported core set of symptoms to measure in adult cancer treatment trials. J Natl Cancer Inst. 2014;106(7). Abstract
Molster C, Maxwell S, Youngs L, Kyne G, Hope F, Dawkins H, et al. Blueprint for a deliberative public forum on biobanking policy: were theoretical principles achievable in practice? Health Expect. 2013;16(2):211-24. Abstract
Arellano LE, Willett JM, Borry P. International survey on attitudes toward ethics in health technology assessment: An exploratory study. Int J Technol Assess Health Care. 2011;27(1):50-4. Abstract
Jonsson E, Banta HD, Schersten T. Health technology assessment and screening in Sweden. Int J Technol Assess Health Care. 2001;17(3):380-8. Abstract
Basch E, Bennett A, Pietanza CM. Use of patient-reported outcomes to improve the predictive accuracy of clinician-reported adverse events. J Natl Cancer Inst. 2011;103(24):1808-10.
Molster C, Potts A, McNamara B, Youngs L, Maxwell S, Dawkins H, et al. Informing public health policy through deliberative public engagement: perceived impact on participants and citizen-government relations. Genet Test Mol Biomarkers. 2013;17(9):713-8. Abstract
Izquierdo F, Gracia J, Guerra M, Blasco JA, Andradas E. Health technology assessment-based development of a Spanish breast cancer patient decision aid. Int J Technol Assess Health Care. 2011;27(4):363-8. Abstract
Granados A, Sampietro-Colom L, Asua J, Conde J, Vazquez-Albertino R. Health technology assessment in Spain. Int J Technol Assess Health Care. 2000;16(2):532-59. Abstract